Effects of transcranial direct current stimulation in children and young people with psychiatric disorders: a

Lucy Gallop1, Samuel J Westwood2,3, Yael Lewis4,5,6

  • 1Section of Eating Disorders, Department of Psychological Medicine, Institute of Psychiatry, Psychology & Neuroscience, King's College London, De Crespigny Park, PO Box 59, London, SE5 8AF, UK. lucy.gallop@kcl.ac.uk.

Insights

Transcranial direct current stimulation (tDCS) shows promise for children and young people with psychiatric disorders, with most studies reporting symptom improvement. However, more research is needed to confirm its effectiveness for clinical symptoms, mood, and cognition.

Area of Science:

  • Neuroscience
  • Psychiatry
  • Clinical Psychology

Background:

  • Transcranial direct current stimulation (tDCS) is used in adults for psychiatric disorders.
  • Its efficacy in children and young people (CYP) with psychiatric disorders is not well-established.

Purpose of the Study:

  • To systematically review the effects of tDCS on psychiatric symptoms, mood, and neurocognition in CYP.
  • To assess the quality of published and ongoing tDCS studies in this population.

Main Methods:

  • PRISMA systematic review of published and ongoing studies up to December 2022.
  • Searched Medline, Embase, PsychINFO, and Clinicaltrials.gov for studies involving CYP (≤25 years) with psychiatric disorders.
  • Two independent raters assessed study eligibility and extracted data.

Main Results:

  • 33 eligible studies (N=517) found that most reported improvements in disorder-specific symptoms.
  • 13 studies examining mood and neurocognition showed mainly positive findings.
  • tDCS was generally well-tolerated with minimal side effects.
  • Ongoing studies (n=11) are often sham-controlled RCTs with improved methodology.

Conclusions:

  • Current evidence is insufficient to definitively conclude tDCS benefits clinical symptoms, mood, or cognition in CYP with psychiatric disorders.
  • Ongoing studies suggest improved methodological rigor.
  • Future research should expand outcome measures and establish optimal tDCS treatment regimens.